Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Cited by (1,007)

Items 801–900 of 1,007

1. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients
   Serpil Erdoğan, Halef Okan Doğan, Sevilay Sezer, Sema Uysal, Esra Uçaryılmaz Özhamam, Serra Kayaçetin, Yüksel Koca · 2013 · Scandinavian Journal of Clinical and Laboratory Investigation
2. Identification of liver fibrosis in HIV/HCV‐coinfected patients using a simple predictive model based on routine laboratory data
   Juan Berenguer, José María Bellón, Pilar Miralles, Enrique L. Álvarez, Matilde Sánchez‐Conde, Jaime Cosín, Juan Carlos López, F. Álvarez, Pilar Catalán, Salvador Resino · 2007 · Journal of Viral Hepatitis
3. Histologic Disease in Chinese Chronic Hepatitis B Patients With Low Viral Loads and Persistently Normal Alanine Aminotransferase Levels
   Hong Wang, Guo Qing Ru, Rong Yan, Yin Zhou, Ming Shan Wang, Mei Juan Cheng · 2016 · Journal of Clinical Gastroenterology
4. CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment
   Mark Hull, Stephen D. Shafran, Alex Wong, Alice Lin-In Tseng, Pierre Giguère, Lisa L. Barrett, Shariq Haider, Brian Conway, Marina B. Klein, Curtis Cooper · 2016 · Canadian Journal of Infectious Diseases and Medical Microbiology
5. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9
   Anastasia Hyrina, Andrea D. Olmstead, Paul Steven, Mel Krajden, Edward Tam, François Jean · 2017 · EBioMedicine
6. Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study
   Lisa C. Adams, Falk Lübbe, Keno K. Bressem, Moritz Wagner, Bernd Hamm, Marcus R. Makowski · 2018 · PLoS ONE
7. Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naïve HBeAg-positive patients with chronic hepatitis B
   Dachuan Cai, Chen Pan, Weihua Yu, Shuangsuo Dang, Jia Li, Shanming Wu, Nan Jiang, Maorong Wang, Zhaohua Zhang, Feng Lin et al. · 2019 · Medicine
8. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset
   J. Morgan Freiman, Jianing Wang, Philippa Easterbrook, Charles Robert Horsburgh, Francesco Marinucci, Laura Forsberg White, George Kamkamidze, Mel Krajden, Anne Loarec, Richard Njouom et al. · 2019 · Journal of Hepatology
9. Individualized risk prediction of significant fibrosis in non‐alcoholic fatty liver disease using a novel nomogram
   Yujie Zhou, Fangzhou Ye, Yangyang Li, Xiao-Yan Pan, Yingxiao Chen, Xixi Wu, Jiao-Jiao Xiong, Wen‐Yue Liu, Shihao Xu, Yong‐Ping Chen et al. · 2019 · United European Gastroenterology Journal
10. Profiles of advanced hepatic fibrosis evaluated by FIB‐4 index and shear wave elastography in health checkup examinees
    Sakura Yamamura, Takumi Kawaguchi, Dan Nakano, Yoshiko Tomiyasu, Shinobu Yoshinaga, Yumi Doi, Hirokazu Takahashi, Keizo Anzai, Yuichiro Eguchi, Takuji Torimura et al. · 2019 · Hepatology Research
11. Consensus on the diagnosis and treatment of hepatic fibrosis (2019)
    Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association · 2020 · Journal of Digestive Diseases
12. Evaluation of NAFLD and fibrosis in obese patients – a comparison of histological and clinical scoring systems
    Sophia M. Schmitz, Andreas Kroh, Tom Florian Ulmer, Julia Andruszkow, Tom Luedde, Jonathan Frederik Brozat, Ulf P. Neumann, Patrick H. Alizai · 2020 · BMC Gastroenterology
13. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
    Min Chul Kim, Jeong In Lee, Jung Hee Kim, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim, Won Sohn · 2020 · PLoS ONE
14. Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis
    Neta Gotlieb, Naama Schwartz, Shira Zelber‐Sagi, Gabriel Chodick, Varda Shalev, Oren Shibolet · 2020 · World Journal of Gastroenterology
15. Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
    Hae Won Yoo, Jun Yong Park, Sang Gyune Kim, Young Kul Jung, Sae Hwan Lee, Moon Young Kim, Dae Won Jun, Jae Young Jang, Jin Woo Lee, Oh Sang Kwon · 2022 · Scientific Reports
16. Serum cadmium is associated with hepatic steatosis and fibrosis
    Seogoo Han, Gi-Ho Sung, Sangheun Lee, Ki Jun Han, Hyun-Jeong Han · 2022 · Medicine
17. Chronic hepatitis C: Diagnosis and treatment made easy
    Naim Abu‐Freha, Binil Mathew Jacob, Ali Elhoashla, Zaid Afawi, Talab Abu-Hammad, Foad Elsana, Sergey Paz, Ohad Etzion · 2022 · European Journal of General Practice
18. Systematic review: hepatic fibrosis – regression with therapy
    Christos D. Zois, Gerasimos Baltayiannis, Peter Karayiannis, Epaminondas V. Tsianos · 2008 · Alimentary Pharmacology & Therapeutics
19. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
20. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity
    Laura E. Dichtel, Kathleen E. Corey, Melanie S. Haines, Mark L Chicote, Allison Kimball, Caitlin Colling, Tracey G. Simon, Michelle T. Long, Jad S. Husseini, Miriam A. Bredella et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
21. SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong
    Chi‐Ho Lee, Lung‐Yi Mak, Eric Ho Man Tang, David Tak Wai Lui, Jimmy Ho‐Cheung Mak, Lanlan Li, Tingting Wu, Wing‐Lok Chan, Man‐Fung Yuen, Karen S.L. Lam et al. · 2023 · Hepatology
22. Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD
    Charu, Vivek, Liang, Jane W., Mannalithara, Ajitha, Kwong, Allison, Tian, Lu, Kim, W. Ray · 2024 · Hepatology
23. Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management
    Philip James Johnson, Anton Kalyuzhnyy, Ellen Boswell, Hidenori Toyoda · 2024 · BJC Reports
24. A roadmap for clinical trials in MASH-related compensated cirrhosis
    Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustín, Ramon A. Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven Francque, Juan G. Abraldeṣ, Virginia Hernández–Gea, Mònica Pons et al. · 2024 · Nature Reviews Gastroenterology & Hepatology
25. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C
    Paul Calès, Jérôme Boursier, Alexandra Ducancelle, Frédéric Oberti, Isabelle Hubert, Gilles Hunault, Victor de Lédinghen, Jean‐Pierre Zarski, Dominique Salmon, Françoise Lunel et al. · 2013 · Liver International
26. LecT-hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients
    Kiyoaki Ito, Atsushi Kuno, Yuzuru Ikehara, Masaya Sugiyama, Hiroaki Saito, Yoshihiko Aoki, Teppei Matsui, Masatoshi Imamura, Masaaki Korenaga, Kazumoto Murata et al. · 2012 · Hepatology
27. An MLP Classifier for Prediction of HBV-Induced Liver Cirrhosis Using Routinely Available Clinical Parameters
    Yuan Cao, Zhi-De Hu, Xiaofei Liu, Anmei Deng, Chengjin Hu · 2013 · Disease Markers
28. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection
    Ayman Yosry, Rabab Fouad, Shereen Abdel Alem, Aisha Mahmoud Elsharkawy, Mohammad El-Sayed, Noha Asem, Ehsan Hassan, Ahmed Ramadan Ismail, Gamal Esmat · 2016 · Arab Journal of Gastroenterology
29. Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis
    Eiichi Ogawa, Norihiro Furusyo, Naoki Yamashita, Akira Kawano, Kazuhiro Takahashi, Kazufumi Dohmen, Makoto Nakamuta, Takeaki Satoh, Hideyuki Nomura, Koichi Azuma et al. · 2016 · Hepatology Research
30. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
    Yuta Aida, Hiroshi Abe, Yoichi Tomita, Tomohisa Nagano, Nobuyoshi Seki, Tomonori Sugita, Munenori Itagaki, Haruya Ishiguro, Satoshi Sutoh, Yoshio Aizawa · 2014 · Europe PMC (PubMed Central)
31. Clinical Predictors of Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection From Children to Adults
    Jia‐Feng Wu, Shih-Hsi Song, Chee‐Seng Lee, Huey‐Ling Chen, Yen‐Hsuan Ni, Hong‐Yuan Hsu, Tzee‐Chung Wu, Mei‐Hwei Chang · 2018 · The Journal of Infectious Diseases
32. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
    Seong Kyun Na, Byung‐Cheol Song · 2019 · Clinical and Molecular Hepatology
33. Clinical significance of elevated liver transaminases in HIV-infected patients
    Jia Xi Cai, Maria Osikowicz, Giada Sebastiani · 2019 · AIDS
34. Impact of Direct Acting Antiviral (DAA) Treatment on Glucose Metabolism and Reduction of Pre-diabetes in Patients with Chronic Hepatitis C
    Philip Weidner, Dominik Boettche, Thomas Zimmerer, Elke Burgermeister, Andreas Teufel, Matthias P. Ebert, Christoph Antoni · 2018 · Journal of Gastrointestinal and Liver Diseases
35. A Simplified Algorithm for the Management of Hepatitis C Infection.
    Douglas T. Dieterich · 2019 · PubMed Central
36. Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools
    Sonja Lang, Fedja Farowski, Anna Martin, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild, Marcin Jan Krawczyk, Angela Nowag, Anne Kretzschmar, Claus Jürgen Scholz, Philipp Kasper et al. · 2020 · Scientific Reports
37. The metabolic profiles and body composition of lean metabolic associated fatty liver disease
    Yu‐Ming Cheng, Jia‐Horng Kao, Chia‐Chi Wang · 2021 · Hepatology International
38. The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
    Mary Barbara, Ayse L. Mindikoglu · 2021 · Metabolism Open
39. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease
    Ajay Kumar. Duseja, Shivaram Prasad Singh, Manu Mehta, S. Shalimar, Jayanthi Venkataraman, Varun Mehta, Krishnadas Devadas, Sanjib K. Kar, Omesh Goyal, Aabha S. Nagral et al. · 2022 · Metabolic Syndrome and Related Disorders
40. Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD
    Nobuharu Tamaki, Kento Imajo, Suzanne R. Sharpton, Jinho Jung, Nancy Sutter, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia A. Behling, Claude B. Sirlin et al. · 2022 · Clinical Gastroenterology and Hepatology
41. Corticosteroid plus glycyrrhizin therapy for chronic drug‐ or herb‐induced liver injury achieves biochemical and histological improvements: a randomised open‐label trial
    Jiabo Wang, Ang Huang, Yijin Wang, Dong Ji, Qingsheng Liang, Jun Zhao, Guangde Zhou, Ming Niu, Ming Niu, Ying Sun et al. · 2022 · Alimentary Pharmacology & Therapeutics
42. Other non-invasive markers of liver fibrosis
    Vincent Leroy · 2008 · Gastroentérologie Clinique et Biologique
43. Advanced liver fibrosis by transient elastography, F ibrosis 4, and alanine aminotransferase/platelet ratio index among A sian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels
    Anchalee Avihingsanon, Salyavit Jitmitraparp, Pisit Tangkijvanich, Reshmie Ashmanie Ramautarsing, Tanakorn Apornpong, Supunee Jirajariyavej, Opass Putcharoen, Sombat Treeprasertsuk, Srunthron Akkarathamrongsin, Yong Poovorawan et al. · 2014 · Journal of Gastroenterology and Hepatology
44. Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones
    Carmelo García‐Monzón, Javier Vargas‐Castrillón, José Luis Porrero Carro, María Teresa Alonso, Óscar Bonachía, María José Castillo, Alberto Marcos, Esther Quirós, Beatriz Ramos, Carlos Sánchez‐Cabezudo et al. · 2015 · Liver International
45. Hepatitis B virus core‐related antigen levels predict progression to liver cirrhosis in hepatitis B carriers
    Toshifumi Tada, Takashi Kumada, Hidenori Toyoda, Natsuko Kobayashi, Tomoyuki Akita, Junko Tanaka · 2017 · Journal of Gastroenterology and Hepatology
46. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection
    Zhujun Cao, Z. Li, Y. Wang, Y. Liu, Ruidong Mo, P. Ren, Lihong Chen, Jie Li Lu, Hongliang Li, Y. Zhuang et al. · 2017 · Journal of Viral Hepatitis
47. Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus
    Yoshihiko Tachi, Takanori Hirai, Hidenori Toyoda, Toshifumi Tada, Kazuhiko Hayashi, Takashi Honda, Masatoshi Ishigami, Hidemi Goto, Takashi Kumada · 2015 · PLoS ONE
48. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
    Behari, Jaideep, Gougol, Amir, Wang, Renwei, Luu, Hung N., Paragomi, Pedram, Yu, Yi-Chuan, Molinari, Michele, Chopra, Kapil, Malik, Shahid M., Geller, David et al. · 2023 · Hepatology Communications
49. Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response
    Sebastiano Leone, Mattia Prosperi, Silvia Costarelli, Paola Nasta, F. Maggiolo, Simona Di Giambenedetto, Annalisa Saracino, Massimo Di Pietro, Andrea Gori · 2016 · European Journal of Clinical Microbiology & Infectious Diseases
50. Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
    Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, Enrica Baldelli, Mariano Capitelli, Amedeo Lonardo · 2023 · Metabolism and Target Organ Damage
51. Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper
    Frank A.J.A. Bodewes, Alvin Jay Freeman, Alexander Weymann, Dominique Debray, Isabelle Scheers, Henkjan J. Verkade, Michael R. Narkewicz · 2024 · Journal of Pediatric Gastroenterology and Nutrition
52. Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort
    Theresa Hydes, Oliver John Kennedy, Kate Glyn‐Owen, Ryan Malcolm Buchanan, Julie Parkes, Daniel James Cuthbertson, Paul Roderick, Christopher D. Byrne · 2024 · Clinical Gastroenterology and Hepatology
53. Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms
    Μargarita Papatheodoridi, Victor de Lédinghen, Monica Lupșor‐Platon, F. Bronte, Jérôme Boursier, Omar Elshaarawy, Fabio Marra, Maja Sofie Thiele, Georgios Markakis, Audrey Payancé et al. · 2024 · Journal of Hepatology
54. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage
    Pamela Valva · 2016 · World Journal of Gastroenterology
55. Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes
    Maik Pietzner, Kathrin Budde, Georg Homuth, Gabi Kastenmüller, Ann‐Kristin Henning, Anna Artati, Jan Krumsiek, Henry Völzke, Jerzy Adamski, Markus M. Lerch et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
56. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma
    Yi Zhang, Rong Wang, Xianjin Yang · 2018 · Medicine
57. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread
    Ning Lyu, Yanan Kong, Tao Pan, Luwen Mu, Shaolong Li, Yaru Liu, Haijing Deng, Jibin Li, Ming Shi, Li Xu et al. · 2019 · Journal of Vascular and Interventional Radiology
58. Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease
    Dong Won Park, Yoon Jin Lee, Won Chang, Ji Hoon Park, Kyoung Ho Lee, Young Hoon Kim, Nam Kyu Kang, Jung Wha Chung, Hee Yoon Jang, Soomin Ahn et al. · 2019 · PLoS ONE
59. Liver Ultrasound Patterns in Children With Cystic Fibrosis Correlate With Noninvasive Tests of Liver Disease
    Simon C. Ling, Wen Ye, Daniel H. Leung, Oscar M. Navarro, Alexander Weymann, Wikrom W. Karnsakul, Alvin Jay Freeman, John C. Magee, Michael R. Narkewicz · 2019 · Journal of Pediatric Gastroenterology and Nutrition
60. Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.
    Hirsh D. Trivedi, Steven C. Lin, Daryl Lau · 2017 · PubMed Central
61. Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease
    Lindsay T. Fourman, Takara Leah Stanley, Isabel Zheng, Chelsea S. Pan, Meghan N. Feldpausch, Julia Purdy, Julia Aepfelbacher, Colleen G. Buckless, Andrew Tsao, Kathleen E. Corey et al. · 2020 · Clinical Infectious Diseases
62. Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
    Wei‐Chen Lin, Yang‐Sheng Lin, Chen‐Wang Chang, Ching-Wei Chang, Tsang-En Wang, Horng‐Yuan Wang, Ming‐Jen Chen · 2020 · PLoS ONE
63. Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States
    Ming Yang, Neehar D. Parikh, Huixin Liu, Elizabeth Wu, Huiying Rao, Bo Feng, Andy Lin, Lai Wei, Anna Suk-Fong Lok · 2020 · Scientific Reports
64. Incidence, Predictors, and Mortality in Patients With Liver Cancer After Fontan Operation
    Hideo Ohuchi, Yohsuke Hayama, Kimiko Nakajima, Kenichi Kurosaki, Isao Shiraishi, Michikazu Nakai · 2021 · Journal of the American Heart Association
65. Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B
    Mandana Khalili, David Erwin Kleiner, Wendy C. King, Richard K. Sterling, Marc G. Ghany, Raymond T. Chung, Atul K. Bhan, Philip Jon Rosenthal, Mauricio Lisker‐Melman, Rageshree Ramachandran et al. · 2021 · The American Journal of Gastroenterology
66. Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
    Yujie Zhou, Feng Gao, Wen‐Yue Liu, Grace Lai‐Hung Wong, Sanjiv Mahadeva, Nik Raihan Nik Mustapha, Xiao‐Dong Wang, Wah‐Kheong Chan, Vincent Wai‐Sun Wong, Ming‐Hua Zheng · 2021 · Alimentary Pharmacology & Therapeutics
67. Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up
    Juan Antonio Sorda, Esteban González Ballerga, Fernando Javier Barreyro, Alejandra Avagnina, Pilar Carballo, Andrea Páes de Lima, Jorge R Daruich · 2021 · Alimentary Pharmacology & Therapeutics
68. Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis
    Zobair M. Younossi, Linda L Henry · 2021 · Endocrine Practice
69. Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?
    Constantinos Pantelis Zambirinis, Abhishek Midya, Jayasree Chakraborty, Joanne F. Chou, Jian Zheng, Caitlin A. McIntyre, Maura A. Koszalka, Tiegong Wang, Richard K. Do, Vinod P. Balachandran et al. · 2022 · Annals of Surgical Oncology
70. Association between liver fibrosis and incident dementia in the UK Biobank study
    Neal S. Parikh, Hooman Kamel, Cenai Zhang, Sonal Rajesh Kumar, Russell Evan Rosenblatt, Pascal Spincemaille, Ajay Kumar Gupta, David E. Cohen, Mony J. de Leon, Rebecca F. Gottesman et al. · 2022 · European Journal of Neurology
71. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
    Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle Schafer, Margaret E. Pearce et al. · 2022 · Journal of Cardiovascular Development and Disease
72. Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD
    Asako Nogami, Masato Yoneda, Michihiro Iwaki, Takashi Kobayashi, Takaomi Kessoku, Yasushi Honda, Yuji Ogawa, Kento Imajo, Takuma Higurashi, Kunihiro Hosono et al. · 2022 · Scientific Reports
73. Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
    Clémence M. Canivet, Jérôme Boursier · 2022 · Diagnostics
74. Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami*
    Marianna K. Baum, S Sales, DT Jayaweera, Shenghan Lai, Gary Bradwin, Carlin L. Rafie, J. Bryan Page, Adriana L. Campa · 2010 · HIV Medicine
75. Management Complexities of HIV/Hepatitis C Virus Coinfection in the Twenty-First Century
    Vincent Lo Re, Jay R. Kostman, Valerianna Amorosa · 2008 · Clinics in Liver Disease
76. Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease
    Takanori Ito, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Tetsuya Ishikawa, Hidenori Toyoda, Takashi Kumada, Mitsuhiro Fujishiro · 2019 · European Journal of Gastroenterology & Hepatology
77. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center
    Daniela Oliveira de Lima Taranto, Thais Cristine Moura Guimarães, Cláudia Alves Couto, Ana Lúcia Cândido, Rosana C. Azevedo, Fernanda Souza Mattos, Maria Luiza Cândido Elias, Fernando Marcos dos Reis, Ana Luiza Lunardi Rocha, Luciana Costa Faria · 2020 · Archives of Endocrinology and Metabolism
78. Predicting Post-Hepatectomy Liver Failure in HCC Patients: A Review of Liver Function Assessment Based on Laboratory Tests Scores
    Alessio Morandi, Matteo Risaliti, Michele Montori, Simone Buccianti, Ilenia Bartolini, Luca Moraldi · 2023 · Medicina
79. Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis
    Rong Fan, Ning Yu, Guanlin Li, Tamoore Arshad, Wen‐Yue Liu, Grace Lai‐Hung Wong, Xieer Liang, Yongpeng Chen, Xiaozhi Jin, Howard H.W. Leung et al. · 2023 · Liver International
80. Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery
    Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, Robert J. Caiazzo, Chiara Saponaro, Guillaume Lassailly, Hélène Verkindt, Grégory Baud, Camille Marciniak, Mikaël Chetboun et al. · 2024 · Metabolism
81. Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
    Chinmay Bera, Nashla Hamdan‐Pérez, Keyur Patel · 2024 · Journal of Clinical Medicine
82. Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
    Joost Boeckmans, Jürgen H. Prochaska, Alexander Gieswinkel, Michael Böhm, Philipp Sebastian Wild, Jörn Markus Schattenberg · 2024 · The Lancet Regional Health - Europe
83. Use of the AST to platelet ratio index in HCV/HIV co‐infected patients
    Amit G. Singal, Lisa V. Thomassen, David R. Gretch, Margaret C. Shuhart · 2011 · Alimentary Pharmacology & Therapeutics
84. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
    Salvador Resino, José María Bellón, Cristina Asensio, Dariela Micheloud, Pilar Miralles, Ana Vargas, Pilar Catalán, Juan Carlos López, Emilio Álvarez, Jaime Cosín et al. · 2010 · BMC Infectious Diseases
85. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results
    Ömer Başar, Barış Yımaz, Fuat Ekız, Zeynep Giniş, Akif Altınbaş, Bora Aktaş, Yaşar Tuna, Şahin Çoban, Namık Delibaş, Osman Yüksel · 2013 · Clinics and Research in Hepatology and Gastroenterology
86. Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
    Bahadır Ceylan, Muzaffer Fıncancı, Ahmet Cem Yardımcı, Gülhan Eren, Ümit Tözalgan, Cüneyt Müderrisoğlu, Esra Paşaoğlu · 2013 · European Journal of Gastroenterology & Hepatology
87. Non‐alcoholic fatty liver disease ( NAFLD ) fibrosis score predicts 6.6‐year overall mortality of C hinese patients with NAFLD
    Yunhao Xun, Jian‐chun Guo, Guo‐qiang Lou, Yanming Jiang, Zhenjie Zhuang, Mengfei Zhu, Yan Luo, Xiaojie Ma, Jing Liu, Dongxue Bian et al. · 2014 · Clinical and Experimental Pharmacology and Physiology
88. Treatment of HCV in the Department of Corrections in the Era of Oral Medications
    Richard K. Sterling, Reena Cherian, Shawn Lewis, Kathleen Genther, Carolyn J. Driscoll, Kelly Martin, Mary Beth Goode, Scott C. Matherly, Mohammad Shadab Siddiqui, Velimir A. Luketic et al. · 2018 · Journal of Correctional Health Care
89. Fibrosis-4 index reflects right-sided filling pressure in patients with heart failure
    Daichi Maeda, Kazushi Sakane, Takahide Ito, Yumiko Kanzaki, Koichi Sohmiya, Masaaki Hoshiga · 2019 · Heart and Vessels
90. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease
    Wen‐Yue Liu, Kenneth I. Zheng, Xiao‐Yan Pan, Hong‐Lei Ma, Pei‐Wu Zhu, Xixi Wu, Rafael S. Rios, Giovanni Targher, Christopher D. Byrne, Xiao‐Dong Wang et al. · 2019 · Journal of Gastroenterology and Hepatology
91. Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?
    Rosa María López, Andrea Arias-García, Francisco Rodríguez-Algarra, Laura Castellote Bellés, Ariadna Rando‐Segura, Guillermo Tarrasó, Elena Vargas‐Accarino, Isabel Montserrat-Lloan, Albert Blanco‐Grau, Andrea Caballero et al. · 2019 · Journal of Clinical Microbiology
92. Liver Stiffness Measured with Two-dimensional Shear-Wave Elastography Is Predictive of Liver-related Events in Patients with Chronic Liver Disease Due to Hepatis B Viral Infection
    Manli Wu, Lili Wu, Jieyang Jin, Jinfen Wang, Shuoyang Li, Jie Zeng, Huanyi Guo, Jian Zheng, Shigao Chen, Rongqin Zheng · 2020 · Radiology
93. The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective
    Amr Dokmak, Blanca Lizaola‐Mayo, Hirsh D. Trivedi · 2020 · The American Journal of Medicine
94. Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
    Georgios Sfikas, Michael Psallas, Charalambos Koumaras, Konstantinos P. Imprialos, Evangelos Perdikakis, Michael N. Doumas, Όλγα Γιουλεμέ, Asterios I. Karagiannis, Vasilios Gabriel Athyros · 2020 · Current Vascular Pharmacology
95. Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin
    Saad Saffo, David Edward Kaplan, Nadim Mahmud, Marina Serper, Binu V. John, Joseph S. Ross, Tamar Hamosh Taddei · 2021 · Diabetes Obesity and Metabolism
96. Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study
    Satoshi Shinozaki, Toshiyuki Tahara, Alan Kawarai Lefor, Masahito Ogura · 2021 · Clinical and Experimental Hepatology
97. Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke
    Simon Fandler‐Höfler, Rudolf E Stauber, Markus Kneihsl, Gerit Wünsch, Melanie Haidegger, Birgit Poltrum, Alexander Pichler, Hannes Deutschmann, Christian Enzinger, Peter Fickert et al. · 2021 · Therapeutic Advances in Neurological Disorders
98. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Digestive and Liver Disease
99. The digital transformation of hepatology: The patient is logged in
    Tiffany E. Wu, Douglas Alano Simonetto, John David Halamka, Vijay H. Shah · 2022 · Hepatology
100. The Natural History of Advanced Chronic Liver Disease Defined by Transient Elastography
     Jessica E. Shearer, Rebecca L. Jones, Richard Parker, James Ferguson, Ian A.C. Rowe · 2022 · Clinical Gastroenterology and Hepatology